BIB

ProShares Ultra Nasdaq Biotechnology [BIB] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BIB Stock Summary

Top 10 Correlated ETFs

BIB


Top 10 Correlated Stocks

BIB


In the News

11:01 22 Feb 2024 BIB

Equity CEFs/ETFs: Top Picks For 2024 - Part II

In Part I of my Top Picks For 2024, I explained why we saw such extreme valuation losses in most equity CEFs in 2023 and what that could-mean for 2024. In my opinion, liquidity was the over-riding factor for why so few stocks, think Magnificent 7, received the lion's share of buy-interest while most everything else suffered, including equity CEFs. But just because the Federal Reserve will continue its Quantitative Tapering doesn't mean that other Fed programs won't increase liquidity in other places.

06:00 22 Feb 2024 BIB

The 7 Best ETFs to Buy to Cover 2023's Biggest Investing Opportunities

These are some of the best ETFs to buy and hold heading into New Year 2023. Rather than being completely tied to the ebb and flow of single-stock ideas, you can gain access to a broad number of similar opportunities at a low price.

06:21 22 Feb 2024 BIB

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond

Some of the hottest biotech stocks are safe and recession-proof. After all, we can't stop people from aging – at least, not yet.

04:45 22 Feb 2024 BIB

Why Now Could Be The Time To Consider Neuroscience Investments

Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomics and immunology, new diagnostics and surgeries, and reductions in stigma associated with mental health are unlocking radical progress in neuroscience this decade akin to the genomics revolution of the past two decades.

04:19 22 Feb 2024 BIB

Top Performing Leveraged/Inverse ETFs: 08/07/2022

Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

01:53 22 Feb 2024 BIB

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in development, hasn't received FDA approval, or hasn't been in the market long enough to establish a proven track record.

01:55 22 Feb 2024 BIB

How to Invest in Biotech in 2022

It's been a hard year for a lot of the biotech industry, with many hedge funds ending the year with significant losses, but there have been a number of shining stars that are expected to continue to offer investors great performance opportunities. The Wall Street Journal reports that investors who focused on COVID-19 stocks, short [.

09:25 22 Feb 2024 BIB

Take a Look at the Top-Performing Biotech ETFs YTD

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.

12:14 22 Feb 2024 BIB

Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs

Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.

01:10 22 Feb 2024 BIB

Pfizer-BioNTech COVID-19 Vaccine Garners Full FDA Approval

The FDA has officially given full approval to Pfizer and BioNTech for their COVID-19 vaccine, potentially making way for more approvals and more vaccine mandates, reports CNBC. It is a move that officials are hoping will encourage those who have been reluctant to receive a vaccine to get vaccinated.

BIB Financial details

Company Rating
-
Market Cap
91.01M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.04
Dividend %
0.06%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-1.72%
SMA50
21.28%
SMA100
18.75%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
1.59M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
40.1-61.37
52W High
-4.69%
52W Low
+45.35%
RSI
53
Rel Volume
0.23
Avg Volume
33.32K
Volume
7.5K
Perf Week
6.13%
Perf Month
-3.73%
Perf Quarter
11.08%
Perf Half Y
12.33%
-
-
-
-
Beta
1.26
-
-
Volatility
0.65%, 1.06%
Prev Close
1.73%
Price
58.14
Change
2.45%

BIB Financial Performance

BIB Frequently Asked Questions

What is ProShares Ultra Nasdaq Biotechnology stock symbol ?

ProShares Ultra Nasdaq Biotechnology is a US stock and trading under the symbol BIB

What is ProShares Ultra Nasdaq Biotechnology stock quote today ?

ProShares Ultra Nasdaq Biotechnology stock price is $58.14 today.

Is ProShares Ultra Nasdaq Biotechnology stock public?

Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap